N/A
Completed N=204
Lifeflight: Fentanyl Versus Morphine
Pain Relief · Adverse Events
Source: ClinicalTrials.gov NCT00580489 ↗
Enrolled (actual)
204
Serious AEs
0.0%
Results posted
Aug 2022
Primary outcomePrimary: Mean Change in Numeric Pain Score (NPS) From First to Last Dose — 2.2; 2.5 score on a scale
Summary
The study is exempt from informed consent by the MetroHealth Medical Center institutional review board (IRB), because two standards of care are used and there is no increased clinical risk to the patient due to the study. The researchers randomize either fentanyl or morphine to be given to trauma patients and record how their pain scale is treated along with observing for adverse events. They are looking to see if the hypothesized benefits of fentanyl (which is much more expensive than morphine) actually exist.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Change in Numeric Pain Score (NPS) From First to Last Dose |
2.2; 2.5 | — |
| SECONDARY Recording of Instance of Narcotic Side Effects. |
0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- Trauma patient
- Able to speak/communicate a pain scale
Exclusion Criteria
- Age 69
- Initially or any time hypotensive
- Prisoner
Data sourced from ClinicalTrials.gov (NCT00580489). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.